N. Hunthausen, Analise LeJeune, Michelle Lee, Callie Weber, Joseph Hargan-Calvopiña, K. Graef, Cathyryne K. Manner, J. Dent
{"title":"WIPO Re: Search: Driving Progress Toward the SDGs by Catalyzing Drug, Diagnostic, and Vaccine Development for Neglected Diseases","authors":"N. Hunthausen, Analise LeJeune, Michelle Lee, Callie Weber, Joseph Hargan-Calvopiña, K. Graef, Cathyryne K. Manner, J. Dent","doi":"10.1109/ghtc46095.2019.9033110","DOIUrl":null,"url":null,"abstract":"Malaria, tuberculosis, and neglected tropical diseases (neglected diseases) affect more than one billion people, mostly in the world's poorest populations, and cost developing economies billions of dollars each year. United Nations Sustainable Development Goal (SDG) Target 3.3 aims to end neglected disease epidemics by 2030. To achieve this ambitious target, expansion of research and development (RD insufficient diagnostic sensitivity and specificity for low-level infections following mass drug administration campaigns; and the growing threat of drug resistance.","PeriodicalId":74562,"journal":{"name":"Proceedings. IEEE Global Humanitarian Technology Conference","volume":"48 1","pages":"1"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings. IEEE Global Humanitarian Technology Conference","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ghtc46095.2019.9033110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Malaria, tuberculosis, and neglected tropical diseases (neglected diseases) affect more than one billion people, mostly in the world's poorest populations, and cost developing economies billions of dollars each year. United Nations Sustainable Development Goal (SDG) Target 3.3 aims to end neglected disease epidemics by 2030. To achieve this ambitious target, expansion of research and development (RD insufficient diagnostic sensitivity and specificity for low-level infections following mass drug administration campaigns; and the growing threat of drug resistance.